Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F Rev.7 /
|
|
- Susanna Stephens
- 7 years ago
- Views:
Transcription
1 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic acid AUG 3 () H.influenzae Ampicillin AMP 2 S. saprophyticus L. monocytogenes Ampicillin AMP βhemolytic group Ampicillin + Sulbactam AMS (+) Azithromycin AZM βhemolytic group H.influenzae H.influenzae ATCC 352 ATCC 496 ATCC 352 ATCC ATCC 3 ATCC 2 ATCC 352 ATCC 3 ATCC 2 ATCC Azlocillin AZL 75 Aztreonam ATM Carbenicillin CAR 0 Cefaclor CEC ATCC ATCC ATCC 352 ATCC 496 Cefadroxil CDX 36 1
2 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Cefamandole MA Cefazolin KZ Cefepime FEP βhemolytic group Cefixime CFM 5 Cefoperazone CFP 75 Cefotaxime CTX βhemolytic group 34 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC Cefotaxime CTX 5 Cefotetan CTT Cefpodoxime PX Cefoxitin FOX and S. lugdunensis Coagulasenegative staphylococci except S. lugdunensis ATCC 496 ATCC 496 ATCC 496 ATCC S. lugdunensis and S. saprophyticus Coagulasenegative staphylococci ATCC 496 ATCC 496 ATCC
3 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Cefprozil CPR ATCC ATCC Ceftaroline CPT 5 Ceftazidime CAZ B. cepacia ATCC Ceftazidime CAZ Ceftibuten CTB Ceftizoxime CZX Ceftriaxone CRO βhemolytic group Cefuroxime CXM (Parenteral) (Oral) (Parenteral) (Oral) (Parenteral (Oral) Cephalothin KF ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC ATCC 496 ATCC Cefuroxime iv Cefuroxime Oral (axetil) (axetil) ATCC 3 ATCC 496 ATCC
4 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Chloramphenicol C βhemolytic group ATCC 496 Cinoxacin CIN 0 32 Ciprofloxacin CIP 5 other than S. typhi and extraintestinal Salmonella spp. S. typhi and extraintestinal Salmonella spp. N. Meningitidis Clarithromycin CLR βhemolytic group Clindamycin CD 2 βhemolytic Group Viridans Group Colistin sulfate CS Doripenem DOR Doxycycline DXT 1 9 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC C. coli ATCC 3 ATCC 496 ATCC 3 ATCC 496 ATCC ATCC 3 ATCC 496 ATCC
5 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Ertapenem ETP Erythromycin E βhemolytic group Fosfomycin (includes G6P) FOS 0 Fusidic acid FC Gatifloxacin GAT 5 βhemolytic group Gentamicin CN ATCC ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC L. monocytogenes C. coli ATCC 496 ATCC 3 ATCC 496 ATCC ATCC 3 32 Coaugulasenegative staphylococci ATCC 3 Gentamicin CN ATCC 2 Imipenem IMI Kanamycin K 32 ATCC 2 ATCC
6 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Levofloxacin LEV 5 S. maltophilia βhemolytic group ATCC Linezolid LNZ Linezolid LNZ βhemolytic group Lomefloxacin LOM Loracarbef LOR ATCC 496 ATCC 496 ATCC ATCC ATCC 3 ATCC 496 ATCC 3 ATCC 2 ATCC 496 Mecillinam MEC Meropenem MRP B. cepacia ATCC L. monocytogenes Methicillin MET 5 Mezlocillin MEZ 75 Minocycline MN B. cepacia S. maltophilia ATCC 496 ATCC 3 ATCC
7 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Moxifloxacin MOX 5 ATCC ATCC 3 ATCC 496 Mupirocin MUP 0 ATCC 3 37 Nafcillin NAF 1 Nalidixic acid NA Netilmicin NET Coagulasenegative Staphylococci Netilmicin NET Nitrofurantoin F 0 Nitrofurantoin F 0 Norfloxacin NOR Ofloxacin OFX 5 βhemolytic group Oxacillin OX 1 Penicillin G P IU βhemolytic group ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC ATCC 3 ATCC 3 ATCC 2 ATCC 496 ATCC 3 ATCC 496 ATCC 3 ATCC ATCC
8 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Penicillin G P 1 IU (screen) L. monocytogenes Piperacillin PRL Piperacillin PRL 0 Piperacillin + Tazobactam TZP 1 (0+) ATCC 352 ATCC Piperacillin + Tazobactam TZP 36 (+6) Polymyxin B PB 0 IU QuinupristinDalfopristin QDA βhemolytic group Rifampicin RD 5 ATCC 496 ATCC (for prophylaxis only) Spectinomycin SPC 0 ATCC 496 Streptomycin S Streptomycin S 0 Teicoplanin TEC ATCC 3 ATCC 496 ATCC 352 ATCC 352 ATCC 3 ATCC 2 ATCC 3 ATCC 496 ATCC 2 ATCC
9 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Telithromycin TEL Tetracycline TE βhemolytic group Ticarcillin TC 75 Ticarcillin + Clavulanic acid TTC 85 (75+) Tigecycline TGC Tobramycin TOB Trimethoprim TM 5 Trimethoprim + Sulfamethoxazole SXT (1.+.75) B. cepacia S. maltophilia ATCC 496 ATCC 496 ATCC 496 ATCC 352 ATCC 352 ATCC 496 ATCC 496 ATCC C. coli Coagulasenegative staphylococci S. maltophilia L. monocytogenes ATCC 496 ATCC 3 ATCC 496 ATCC ATCC 3 ATCC 2 ATCC 496 ATCC 3 ATCC 3 ATCC 2 ATCC 3 ATCC 2 ATCC
10 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Vancomycin VA 5 Vancomycin VA βhemolytic Group Viridans Group ATCC 496 ATCC 2 ATCC 496 Refer to tables of clinical breakpoints. References 1. M0S. Performance Standards for Antimicrobial Susceptibility Testing, January. 2.. Breakpoint tables for interpretation of MICs and zone s, Version 3.0, January. 3. Routine internal quality control as recommended by, Version 3.0, January. 4. Extended quality control as recommended by, Version 1.0, January Disclaimer The present Antibiotic Disk Interpretative Criteria and Quality Control table might be out of date. Check online for the latest update: The present Antibiotic Disk Interpretative Criteria and Quality Control table does not replace the official documents by and. LIOFILCHEM s.r.l. Via Scozia zona ind.le, 640 Roseto degli Abruzzi (Te) Italy Tel Fax liofilchem@liofilchem.net IVD F0 Rev.7 /.02.
Product Catalogue 2015 Clinical and Industrial Microbiology
Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs
More informationDate: November 30, 2010
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application
More informationDrug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director
More informationANTIMICROBIAL AGENT CLASSES AND SUBCLASSES
ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
More informationDetermination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK
Journal of Antimicrobial Chemotherapy (2001) 48, Suppl. S1, 5 16 Determination of minimum inhibitory concentrations JAC Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham
More informationHUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data
More informationHow To Treat Mrsa From A Dead Body
HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on
More informationHUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria
More informationHUSRES Annual Report 2015
HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses
More informationHow To Treat Mrsa In Finnish
HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on
More informationDosing information in renal impairment
No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10
More informationThe 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.
The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013 Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. Aarestrup The 14TH EURL-AR Proficiency Test Enterococci, Staphylococci
More informationfor Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
More informationVersion 11.1 May 2012
BSAC Methods for Antimicrobial Susceptibility Testing Version 11.1 May 2012 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews1@nhs.net Contents Page Working Party members 5
More informationHelsingin ja Uudenmaan alueen herkkyystilastoja 2003. www.infektiofoorumi.fi www.huslab.fi www.intra.hus.fi
Helsingin ja Uudenmaan alueen herkkyystilastoja 2003 www.infektiofoorumi.fi www.huslab.fi www.intra.hus.fi 12 10 Staph. aureus Pus and blood isolates % R+I, at HUCH (7 hospitals) [one isolate/patient (the
More informationSEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance
SEA-HLM-415 Distribution: General Establishment of national laboratory-based surveillance of antimicrobial resistance World Health Organization 2011 All rights reserved. Requests for publications, or for
More informationBD Sensi-Disc Susceptibility Test Discs
INSTRUCTIONS FOR USE BD SENSI-DISCS SD-BD.01 Rev.: May 2005 BD Sensi-Disc Susceptibility Test Discs INTENDED USE Sensi-Disc susceptibility test discs are used for semi-quantitative in vitro susceptibility
More informationVersion 12 May 2013. BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton. Email: Mandy.Wootton@wales.nhs.
BSAC Methods for Antimicrobial Susceptibility Testing Version 12 May 2013 All enquiries to: Mandy Wootton Email: Mandy.Wootton@wales.nhs.uk Telephone: +44 (0) 2920 746581 Contents Page Working Party members
More informationHelsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi
Helsingin ja Uudenmaan alueen herkkyystilastoja 2004 www.huslab.fi www.intra.hus.fi Staph. aureus 2004 (%R+I) Pus and blood isolates at six hospitals (M,T,L,K,N,Ma) in Helsinki University Central Hospital,
More informationAntibiotikaanvändning
Antibiotikaanvändning Akademiska sjukhuset T o m juni 2014 Receptförskriven och rekvirerad antibiotika (J01 inkl rifampicin)* Akademiska sjukhuset 2008 - juni 2014 Källa: ehälsomyndigheten 350 000 300
More informationReceived 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010
J Antimicrob Chemother 2011; 66: 205 209 doi:10.1093/jac/dkq404 Advance Access publication 8 November 2010 Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus
More informationOXOiD KÜLTÜR BESİYERLERİ
AG 020 C OXOID PLASTIC POUCHES for ANAEROGEN & CAMPYGEN 1 x 20 Adet AG 025 A OXOID ANAEROJAR 2.5lt. 1 Adet AG 029 A OXOID ANAEROJAR PLATE CARRIER 1 Adet AN 005 C OXOID SEALING CLIPS for PLASTIC POUCHES
More informationReceived 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2006, p. 4085 4094 Vol. 44, No. 11 0095-1137/06/$08.00 0 doi:10.1128/jcm.00614-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Two-Center
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
More informationAppropriate Treatment for Children with Upper Respiratory Infection
BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:
More informationUrinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
More informationAntimicrobial Therapy. Otolaryngology Head and Neck Surgery
Pocket Guide to Antimicrobial Therapy in Otolaryngology Head and Neck Surgery 13th Edition DAVID N.F. FAIRBANKS, M.D. The American Academy of Otolaryngology Head and Neck Surgery Foundation EMPIRIC DRUG
More informationFORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx
More informationbactericidal Gram+ streptococci, enterococci, meningococci, treponema pallidum (syphilis), most anaerobes poor activity against Gram- rods
Penicillin binds penicillin binding beta-lactamase proteins (transpeptidases, cleaves beta-lactam carboxypeptidases); ring and inactivates enzymes involved in cell drug wall (peptidoglycan) (chromosomal
More informationOscar E. Guzman, PharmD, BCPS
P Chapter 32 Antibiotic Streamlining Oscar E. Guzman, PharmD, BCPS Introduction Antibiotic streamlining is one of the most important methods pharmacists can use to encourage appropriate antibiotic use,
More informationORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01613.x Benchmarking antimicrobial drug use at university hospitals in five European countries V. Vlahović-Palc evski 1, U. Dumpis 2, P. Mitt 3, J. Gulbinovic
More informationAETNA BETTER HEALTH OF OHIO a MyCare Ohio plan
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare
More informationOXOID FİYAT LİSTESİ ÜRÜN AÇIKLAMASI
ANTİBİYOGRAM DİSKLERİ 1 CT 107 B OXOID AMIKACIN 30 μg AK 5x50 Disk 2 CT 061 B OXOID AMOXYCILLIN 25 μg AML 5x50 Disk 3 CT 060 B OXOID AMOXYCILLIN 2 μg AML 5x50 Disk 4 CT 161 B OXOID AMOXYCILLIN 10 μg AML
More informationThe 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011. Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M.
The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011 Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M. Aarestrup European Union Reference Laboratory - Antimicrobial Resistance
More informationAntimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationSHEA Position Paper. Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275
Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275 SHEA Position Paper Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention
More informationCODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C
CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C 53FT200-10 Signal HCV Ver. 2.0 Flow Through 10 Tests 53FT200-50 Signal HCV Ver. 2.0 Flow Through 50 Tests 53EL100-96 Innova ELISA 96 Wells HEPATITIS
More informationANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus bacteraemia annual report, part I The format
More informationANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus Bacteraemia Annual Report, Part I The annual
More informationKey words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.
Nazarchuk Oleksandr, Nahaichuk Vasyl, Paliy Viktor, Kovalenko Iryna. Microbiological aspects of the effectiveness of antimicrobial drugs. Journal of Education, Health and Sport. 2015;5(6):19-28. ISSN 2391-8306.
More information2015 Formulary (List of Covered Drugs)
Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
More informationPractice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections
Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?
More informationPROJECT LIST GENERIC PRODUCTS
PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets
More informationWelcome. Quality. Ethical Statement. Website This Catalogue is available electronically from our website: www.mastgrp.com
IVD solutions through partnership Welcome Welcome to the Mast Group Ltd. Product Catalogue effective from January 1st, 2015. The catalogue comprises ordering information on Mast s extensive portfolio of
More informationTreatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant
More informationPlasmidic Extended-Spectrum -Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2002, p. 1462 1468 Vol. 46, No. 5 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.5.1462 1468.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationClinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
600 ASHP Therapeutic Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP),
More informationHow To Get A Drug Plan To Pay For A Prescription From Acpa
+B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and
More informationA baseline survey of antimicrobial resistance in bacteria from selected New Zealand foods, 2009 2010
A baseline survey of antimicrobial resistance in bacteria from New Zealand foods, 2009 2010 MAF Technical Paper No: 2011/53 Helen Heffernan 1, Teck Lok Wong 2, Jennifer Lindsay 2, Barbara Bowen1 and Rosemary
More informationANTIBIOTICS IN SEPSIS
ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics
More informationBeta-lactam antibiotics - Cephalosporins
Beta-lactam antibiotics - Cephalosporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability ypropertiesp Stability to bacterial
More informationNewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12
Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics
More informationAntimicrobial Susceptibility Patterns of Common and Unusual Enterococcus species Isolated from Clinical Specimens
Original Article Vol. 24 No. 2 Isolation and sensitivity pattern of enterococci:- Chaudhary U, et al. 55 Antimicrobial Susceptibility Patterns of Common and Unusual Enterococcus species Isolated from Clinical
More informationPenetration of Antimicrobial Agents into the Prostate
Pharmacology Chemotherapy 2003;49:269 279 DOI: 10.1159/000074526 Received: December 23, 2002 Accepted after revision: March 18, 2003 Penetration of Antimicrobial Agents into the Prostate Konstantin Charalabopoulos
More informationRapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy
Eur J Clin Microbiol Infect Dis (2015) 34:2385 2394 DOI 10.1007/s10096-015-2492-9 ORIGINAL ARTICLE Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy M. Fredborg
More informationPRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS
PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS SKIN AND SOFT TISSUE INFECTIONS: Mild A. Cellulitis: MRSA uncommonly causes cellulitis in the absence of a wound abscess. Add empiric anti-mrsa therapy
More informationINTRAVENOUS DRUG QUICKGUIDE
INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION
More informationNEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :
LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: locost@sify.com Website: www.locostindia.com A Public
More informationUrinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae
African Journal of Biotechnology Vol. 10(73), pp. 16661-16666, 21 November, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB11.2449 ISSN 1684 5315 2011 Academic Journals Full
More informationPrescription Drug Guide
2012 Prescription Drug Guide Humana Group Medicare Formulary List of covered drugs Humana Group Medicare Plus 3 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Y0040_PDG12b_Final_522C
More informationCAP, HAP, VAP, & HCAP
Objectives Following the presentation, the participant will be able to: CP, HP, VP, & HCP John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota 1. Identify typical, atypical,
More informationVancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4
Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins
More informationAAC Accepts, published online ahead of print on 20 August 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.00614-07
AAC Accepts, published online ahead of print on 20 August 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.00614-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationOptimizing Antimicrobial Susceptibility Test Reporting
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2011, p. S15 S19 0095-1137/11/$12.00 doi:10.1128/jcm.00712-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. VOL. 49, NO. 9 SUPPL. Optimizing
More informationBacterial Infections Caused by Achromobacter xylosoxidans
Bacterial Infections Caused by Achromobacter xylosoxidans Mohammed Kadum Al-Araji Samah Ali College of Pharmacy, Al-Mustanseriyia University, Baghdad, Iraq. Corresponding author: E-mail: mohammedkadum52@yahoo.com
More informationAppendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections
Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections University of Wisconsin Hospital and Clinics Intraabdominal Infections Prophylaxis and Management
More informationOutpatient Parenteral Antimicrobial Therapy
Outpatient Parenteral Antimicrobial Therapy Jason E. Bowling, MD a,b, *, James S. Lewis II, PharmD c,d, Aaron D. Owens, MD a,e KEYWORDS Outpatient parenteral antimicrobial therapy Antibiotics Adverse events
More informationMay 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary
Commercial Triple Tier 4th Tier Applicable Traditional s EVOTAZ 2 2 Alternatives Flovent Diskus/HFA, Pulmicort Flexhaler, Qvar, Asmanex HFA eszopiclone, zaleplon, zolpidem, amitriptyline, mirtazapine,
More informationAMBULATORY SURGERY CENTERS ASTHMA AND RESPIRATORY ILLNESS
The following measures represent NQF-Endorsed voluntary consensus standards for physician-focused ambulatory care and are intended to allow for the standardization of quality measurement in this area.
More informationDisc Diffusion Susceptibility Methods
Disc Diffusion Susceptibility Methods Introduction When a filter paper disc impregnated with a chemical is placed on agar the chemical will diffuse from the disc into the agar. This diffusion will place
More informationObjectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution?
Objectives Intravenous Medications in the Intensive Care Unit Paul Juang, Pharm.D., BCPS Assistant Professor of Pharmacy Practice St. Louis College of Pharmacy April 16, 2011 The speaker has no conflict
More informationPractice Guidelines for the Management of Bacterial Meningitis
IDSA GUIDELINES Practice Guidelines for the Management of Bacterial Meningitis Allan R. Tunkel, 1 Barry J. Hartman, 2 Sheldon L. Kaplan, 3 Bruce A. Kaufman, 4 Karen L. Roos, 5 W. Michael Scheld, 6 and
More informationCatalogue of technologies developed by Polish Research NON-CLINICAL RESEARCH UNITS
Catalogue of technologies developed by Polish Research NON-CLINICAL RESEARCH UNITS 603 INSTITUTE OF BIOTECHNOLOGY AND ANTIBIOTICS (Instytut Biotechnologii i Antybiotyków) Organisation Contact Data 5 Starościńska
More informationTreatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults
1 of 6 9/24/2010 11:16 AM Official reprint from UpToDate www.uptodate.com 2010 UpToDate Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults Author
More informationMagellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs)
Magellan Rx Medicare Basic (PDP) 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE S WE COVER IN THIS PLAN Formulary File 16144, Version 22 This formulary
More informationAntibiotics and Infectious Disease in Otolaryngology-HNS
Antibiotics and Infectious Disease in Otolaryngology-HNS Glen T. Porter, MD Faculty Advisor: Francis B. Quinn, MD, FACS The University of Texas Medical Branch at Galveston Department of Otolaryngology
More informationAnnual Report on Staphylococcus aureus Bacteraemia Cases 2006
Annual Report on Staphylococcus aureus Bacteraemia Cases 2006 STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT, 2006 Members of the Danish Staphylococcus aureus bacteremia group Thomas Benfield, Dr. med.
More informationStreptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7
Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis
More informationAntibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice
MAJOR ARTICLE EMBARGOED UNTIL 12:01 A.M. EDT ON THURSDAY, APRIL 23, 2015 Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice Farha Quadri, 1 Maryann Mazer-Amirshahi, 2 Erin
More informationIDSA GUIDELINES EXECUTIVE SUMMARY
IDSA GUIDELINES Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Joseph
More informationThe State of Therapeutics in Eye Care (Part I)
The State of Therapeutics in Eye Care (Part I) Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO www.eyeupdate.com 1 st World Congress of Optometry Medellin, Columbia August 14-16, 2015 Gilenya First
More informationMARAN 2015. NethMap 2015. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands
NethMap 215 Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands MARAN 215 Monitoring of Antimicrobial Resistance and Antibiotic Usage
More informationMicroMD emr version 7.5
MicroMD emr version 7.5 C l i n i c a l q u a l i t y m e a s u r e c a l c u l at i o n s MICROMD EMR CLINICAL QUALITY MEASURES VERSION 7.5 TRADEMARKS Because of the nature of the material, numerous hardware
More informationRational Selection of Antimicrobials for Use in Horses
Rational Selection of Antimicrobials for Use in Horses W. David Wilson, BVMS, MRCVS, MS Author s address: Department of Medicine and Epidemiology (VM:VME), School of Veterinary Medicine, University of
More informationThe Five Intravenous Antibiotics You Need to Know
The Five Intravenous Antibiotics You Need to Know Ray Geyer, DO Infectious Disease Specialist Medical Director, Benefis Infection Prevention Empirical Antimicrobial Prescribing: Save the Patient and Kill
More informationA role for Propionibacterium acnes in post-operative orthopedic implant infections Katherine P. Lemon, MD PhD Joint ID Conference April 28, 2003
A role for Propionibacterium acnes in post-operative orthopedic implant infections Katherine P. Lemon, MD PhD Joint ID Conference April 28, 2003 In the US annually there are 600,000 joint prostheses and
More informationComplicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria
J Antimicrob Chemother 2010; 65 Suppl 3: iii25 33 doi:10.1093/jac/dkq298 Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria Ann Pallett
More informationNote. 2.0 Background. 1.0 Introduction RECOMMENDATION
Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia
More informationANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 29 Aalborg Viborg Herning Aarhus Hillerød Esbjerg Vejle Herlev København Hvidovre Odense Slagelse Næstved Sønderborg DEAR COLLEAGUE
More informationCalifornia Gonorrhea Treatment Guidelines
Califnia Gonrhea Treatment Guidelines These guidelines were developed by the Califnia Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch in conjunction with the Califnia
More informationIntra-abdominal abdominal Infections
Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal
More informationCefuroxime apollo +9191 46 950 950
Cefuroxime apollo +9191 46 950 950 Cefuroxime apollo +9191 46 950 950 Cefuroxime CAS Number : 55268-75-2 Molecular Weight : 424.385 g/mol Molecular Formula : C16H16N4O8S Systematic (IUPAC) : (6R,7R)-3-
More informationGram negatif bakterilerde GSBL üretiminin üç farklı yöntemle araştırılması ve antibiyotik direnç oranları ÖZET
Araştırma Makalesi/Original Article Makale Dili İngilizce /Article Language English Türk Hijyen ve Deneysel Biyoloji Dergisi Investigation of three different methods for detection of ESBL production and
More informationPLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN.
01 Blue BCN Advantage HMO BCN Advantage HMO-POS Medicare and more Care Network of Michigan is a nonprofit corporation and independent licensee of the Blue Cross and Blue Shield Association. BCN Advantage
More informationNational Surveillance of Invasive Streptococcus pneumoniae and Streptococcus pyogenes In Canada
National Surveillance of Invasive Streptococcus pneumoniae and Streptococcus pyogenes In Canada Annual Summary 2012 Streptococcus and STI Unit Bacteriology and Enteric Diseases Program National Microbiology
More informationCulture and sensitivity pattern of micro-organism isolated from diabetic foot infections in a tertiary care hospital
Int J Cur Biomed Phar Res. 0; (): 0. Contents lists available at CurrentSciDirect Publications International Journal of Current Biomedical and Pharmaceutical Research CurrentSciDirect Publication Journal
More informationBeta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas
Arch Pediatr Infect Dis. 2015 October; 3(4): e26362. Published online 2015 October 12. doi: 10.5812/pedinfect.26362 Research Article Molecular Detection of bla VEB-1 Beta-Lactamase Encoding Gene Among
More informationCMT - Copan Milk Test
- Copan Milk Test for the detection of Antibiotics & Sulphonamides in milk and milk products - Copan Milk Test Copan Milk Test () Description and principle of the test is available as a single test which
More information